FiercePharma RSS Feed (Manufacturing)

Emergent's Baltimore plant flagged for quality control concerns last April, FDA report reveals fkansteiner Fri, 04/09/2021 - 09:45

'Very stressed' Serum Institute asks government for $400M vaccine production boost kdunleavy Thu, 04/08/2021 - 10:10

BeiGene's massive biologics plant in China wins first commercial manufacturing nod fkansteiner Thu, 04/08/2021 - 09:50

Bristol Myers Squibb's regulatory missteps on Breyanzi can't all be blamed on COVID: analyst esagonowsky Thu, 04/08/2021 - 09:39

CDMO Sterling, scaling up for the oncology arms race, acquires U.K. antibody-drug conjugate specialist fkansteiner Tue, 04/06/2021 - 10:53

Takeda's rare disease med Natpara faces long road back to market as manufacturing issues multiply fkansteiner Mon, 04/05/2021 - 15:00

CDMO Ajinomoto to bring AstraZeneca fill-finish work to San Diego plant fkansteiner Mon, 04/05/2021 - 11:11

AstraZeneca is forced to scout for new COVID-19 vaccine manufacturing partner, dealing the launch another setback kdunleavy Mon, 04/05/2021 - 10:47

Chime Bio, flush with $190M, blueprints major biomanufacturing boost in China fkansteiner Mon, 04/05/2021 - 09:19

Moderna shells out for CEO security as its COVID-19 vaccine grabs the spotlight esagonowsky Mon, 04/05/2021 - 09:06

Emergent BioSolutions' plant behind the lost J&J vaccine batch hit with several FDA red flags last year: report fkansteiner Fri, 04/02/2021 - 11:11

Sinovac aims to pump out 2B COVID-19 vaccine doses a year, courtesy of 3rd production line fkansteiner Fri, 04/02/2021 - 09:48

Bristol Myers' Abecma launch tools? Digital CAR-T platform and provider training, for 2 esagonowsky Thu, 04/01/2021 - 09:43

Apotex yanks ADHD med after traces of schizophrenia drug turn up in a single lot fkansteiner Thu, 04/01/2021 - 09:43

FDA downplayed serious red flags at Merck vaccine plant slated for J&J COVID shot, whistleblower says fkansteiner Wed, 03/31/2021 - 18:14

Up to 15M Johnson & Johnson coronavirus vaccine doses ruined due to human error: NYT esagonowsky Wed, 03/31/2021 - 17:53

Nitto Denko lays out $226M to boost oligonucleotide production in a bustling RNA market fkansteiner Wed, 03/31/2021 - 11:36

Daiichi exits combo vaccine pact with Sanofi after pertussis shot manufacturing glitches fkansteiner Wed, 03/31/2021 - 10:01

Pumped by a big year for its flu shots, Sanofi lays out €600M for new vaccine manufacturing plant esagonowsky Wed, 03/31/2021 - 09:18

Johnson & Johnson vaccine partner Emergent still lacks FDA's manufacturing green light fkansteiner Tue, 03/30/2021 - 09:45